Your support helps NAMA make a difference.Treasurer: J.L. Sotheran, PhD, CMA Please confirm your Donation with our Treasurer (with a copy to the Membership Director). |
Your support helps NAMA make a difference.Treasurer: J.L. Sotheran, PhD, CMA Please confirm your Donation with our Treasurer (with a copy to the Membership Director). |
National Alliance of Methadone Advocates Virginia NAMA Addiction Treatment Watchdog Advocates for Recovery through Medicine Date: January 28, 2004 For Immediate Release Contact: Joycelyn Woods [email protected] Charles Kitts [email protected] Phone: (212) 595-6262 Terri Martinez [email protected] Chris Kelly [email protected] Delegate Marshall Long, D-Mercer County, West Virginia, plans to introduce a bill creating new state regulations for…
Number 1 Methadone Maintenance and Patient Self AdvocacyBy Arlene Ford (March, 1991). Number 2 Drug Policy in the Age of AIDS – The Philosophy of Harm ReductionBy Rod Sorge (April, 1991). Number 3 Myths About Methadone By Emmett Velten (March, 1992). Number 4 Methadone, HIV Infection, and Immune FunctionBy Herman Joseph (August, 1994). Number 5…
The Basic Advocacy Training Session The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs. Medication Assisted Treatment Basic clinical information about methadone and buprenorphine treatment. Regulations and Accreditation The federal regulations will be explained: What they are and…
NAMA wishes to thank the National Institute on Drug Abuse (NIDA) and the Center for Substance Abuse Treatment (CSAT) for their Support of Certified Methadone Advocate Training at the 2003 AATOD Conference in Washington DC. NAMA wishes to offer special thanks to Mallinckrodt and American Association for the Treatment of Opioid Dependence (AATOD).
National Alliance of Methadone Advocates Dear Advocates: Since its beginning over 30 years ago methadone maintenance has been the preferred treatment for narcotic addiction by the drug user. Many times it has been demonstrated to be the most effective treatment for heroin addiction, resulting in the termination both of heroin use and of criminal behavior. …
FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…